Skip to main content
Premium Trial:

Request an Annual Quote

Aushon Inks Distribution Agreement with Thermo Fisher

Premium

Aushon Biosystems said this week that it has signed an exclusive distribution agreement with Fisher Scientific – part of Thermo Fisher Scientific – for North American distribution of Aushon's full line of multiplex immunoassay products and services.

Aushon's offerings include its new SignaturePlus multiplexing system, as well as a kit menu of more than 300 protein biomarker assays, analysis software, and CLIA lab services.

The company's multiplex platform has recently been used in several late-stage clinical trials, including phase II and phase III trials led by researchers at the University of Texas MD Anderson Cancer Center investigating protein biomarkers for predicting patient response to the GlaxoSmithKline kinase inhibitor pazopanib.

“We are very pleased that Fisher Scientific has entered this strategic partnership with Aushon, highlighting the potential for our multiplex immunoassay platform in this high growth market,” Joe Blanchard, Aushon's chief business officer, said in a statement. “This partnership will complement our direct sales team and enable us to access the broadest number of scientists in the North American life science community.”

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.